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HoxB4 Confers Definitive Lymphoid-Myeloid
Engraftment Potential on Embryonic Stem Cell
and Yolk Sac Hematopoietic Progenitors
lier studies have identified several homeotic selector
genes that are expressed in definitive HSCs but not in
yolk sac, including HoxB3, B4, A4, and A5 (Sauvageau
et al., 1994; McGrath and Palis, 1997). We tested HoxB4
as a candidate gene to promote definitive potential for
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2 Division of Hematology/Oncology the following reasons: (1) HoxB4 had been shown to
enhance hematopoietic repopulation when overexpressedMassachusetts General Hospital
Harvard Medical School in adult bone marrow, without inducing leukemia or in-
terfering with hematopoietic differentiation (SauvageauBoston, Massachusetts 02115
et al., 1995); (2) HoxB4 had been implicated in self-
renewal of the definitive HSC (Sauvageau et al., 1995);
and (3) HoxB4 had previously been shown to enhanceSummary
the formation of mixed hematopoietic colonies from dif-
ferentiating ES cell cultures (Helgason et al., 1996). InThe extent to which primitive embryonic blood progen-
itors contribute to definitive lymphoid-myeloid hema- this report, we demonstrate that ectopic expression of
HoxB4 endows two types of embryonic hematopoietictopoiesis in the adult remains uncertain. In an effort
to characterize factors that distinguish the definitive progenitors (precirculation yolk sac and ES-derived pro-
genitors) with the potential to engraft and contribute toadult hematopoietic stem cell (HSC) and primitive pro-
genitors derived from yolk sac or embryonic stem (ES) multilineage lymphoid-myeloid hematopoiesis in irradi-
ated adult mice.cells, we examined the effect of ectopic expression of
HoxB4, a homeotic selector gene implicated in self-
renewal of definitive HSCs. Expression of HoxB4 in
primitive progenitors combined with culture on hema- Results
topoietic stroma induces a switch to the definitive HSC
phenotype. These progenitors engraft lethally irradi- HoxB4 Transduction of Yolk Sac Cells
We expressed the HoxB4 cDNA in cells isolated fromated adults and contribute to long-term, multilineage
hematopoiesis in primary and secondary recipients. precirculation murine yolk sac (E8.25, 2–4 somite pair
embryos) using a retrovirus that coexpressed GFP (VanOur results suggest that primitive HSCs are poised to
become definitive HSCs and that this transition can Parijs et al., 1999). Cells were grown on an OP9 stromal
cell layer, previously shown to support maintenance ofbe promoted by HoxB4 expression. This strategy for
blood engraftment enables modeling of hematopoietic hematopoietic progenitors derived from ES cells in vitro
(Nakano et al., 1994). HoxB4-infected cultures gave risetransplantation from ES cells.
to abundant colonies of semiadherent cells with hema-
topoietic blast morphology, while control cultures showedIntroduction
no growth (Figure 1A). Cultured cells were injected into
four lethally irradiated syngeneic adult recipients, whichBlood development in embryoid bodies (EBs) differenti-
ated from ES cells recapitulates yolk sac hematopoiesis were assayed over time for GFP-positive cells in the
peripheral blood (Figure 1C, left). Bone marrow from one(Keller et al., 1993). Like yolk sac progenitors, ES deriva-
tives are ineffective at repopulating hematopoiesis in primary mouse was examined for donor-derived GFP-
positive cells counterstained with antibodies specific forlethally irradiated adults, a property believed to reflect
developmental immaturity or a defect in homing to the myeloid and lymphoid hematopoietic lineages. Recipi-
ents showed donor-derived engraftment of myeloidbone marrow (Mu¨ller and Dzierzak, 1993; Yoder, 2001).
Using the EB differentiation system, we have shown that (Gr-1and Mac-1), B lymphoid (B220), and T lymphoid
(CD4 and CD8) cells (Figure 1B), demonstrating thatprimitive progenitors can generate definitive lymphoid,
myeloid, and erythroid lineages when engraftment is HoxB4 expression confers on precirculation yolk sac
driven by transformation with the Bcr/Abl oncogene cells the capacity for engraftment and multilineage dif-
(Perlingeiro et al., 2001). Likewise, yolk sac progenitors ferentiation in irradiated adults. Donor-derived bone
can contribute to hematopoiesis in the adult when en- marrow cells from primary animals were transplanted
grafted into neonates (Yoder et al., 1997) or when cul- into secondary recipients, where they contributed to
tured on stroma taken from the paraaortic region of multilineage hematopoiesis for at least 5 months, the
the embryo, where definitive HSCs are first detected longest time point analyzed in this study (Figures 1C
(Matsuoka et al., 2001). These data argue that primitive and 1D). However, lymphoid engraftment waned over
embryonic blood progenitors can be induced to become time in secondary animals, an observation we have
definitive lymphoid-myeloid hematopoietic stem cells if linked to the inhibitory effects of constitutive HoxB4
exposed to the proper microenvironment. expression on lymphoid differentiation, as discussed
The molecular mechanisms that distinguish primitive below. Our data demonstrate that HoxB4 expression
and definitive hematopoiesis are largely unknown. Ear- induces definitive hematopoietic stem cell potential in
primitive yolk sac-derived hematopoietic precursors
isolated prior to the onset of circulation.3 Correspondence: daley@wi.mit.edu
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Figure 1. HoxB4-Transduced Yolk Sac Cells In Vitro and In Vivo
(A) (i) A typical colony from HoxB4-infected yolk sac cells grown on OP9 stroma. (ii) A control culture infected with empty vector, showing
only the background of OP9 cells. (iii) Leukostain of cytospin preparation of HoxB4-infected yolk sac cells grown on OP9.
(B) FACS analysis of bone marrow of a representative YS-HoxB4-transplanted mouse. GFP intensity (marking donor cells) is plotted on the
x axis, and intensity of counterstain with lineage-specific markers of hematopoietic differentiation is plotted on the y axis. Negative graph
shows autofluorescence pattern of a nonengrafted mouse; iso graph shows isotype-matched control nonspecific antibody staining of the
engrafted mouse. The host cells, which serve as internal controls for antibody staining, are represented in the left upper and lower quadrants
of all graphs. Percentages represent the fraction of GFP donor cells that express a given differentiation antigen (right upper quadrants, all
graphs).
(C) Percent GFP donor-derived cells in the peripheral blood of primary and secondary recipients as detected at indicated time points
posttransplant. (Left) Four primary mice followed over 10 weeks. (Right) Five secondary mice injected with GFP bone marrow from a primary
mouse followed over 5 months.
(D) FACS analysis of peripheral blood from one secondary recipient stained with the myeloid differentiation marker Gr-1, the B cell marker
B220, and a mixture of CD4 and CD8 to stain T cells.
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Figure 2. Generation of an ES Cell Line Specifying Inducible Transgene Expression
(A) Schematic representation of integrated expression cassettes. The rtTA is integrated into the constitutive ROSA26 locus on chromosome
6. Cre-mediated recombination of targeting vectors into the homing site on the X chromosome restores resistance to the antibiotic G418
(NEO), thereby facilitating efficient isolation of transgenic cells. Abbreviations: tetOP, tetracycline response element; PGK, phosphoglyceroki-
nase promoter; ATG, methionine initiation codon; black triangle, lox recognition sequence for Cre recombinase; GFP, green fluorescent protein;
Neo, truncated neomycin (G418) resistance gene; pA, polyadenylation sequence.
(B) FACS profiles of an ES cell line modified for inducible GFP expression. (i) Uninduced ES cells. (ii) ES cells cultured in media supplemented
with 1 g/ml doxycycline; (iii) ES cells differentiated for 8 days as embryoid bodies and grown for two more days in medium supplemented
with 1 g/ml doxycycline. Percentage of cells gated for GFP positivity is indicated. Channel detecting GFP is indicated on x axis, and
autofluorescence on y axis. An uncompensated, two-dimensional analysis was used to define maximum separation between GFP-positive
and -negative populations.
(C) Western blot of uninduced and induced iHoxB4 cells using a monoclonal antibody to HoxB4.
HoxB4 Induction in Embryoid Body-Derived Cells etic differentiation. To achieve more consistent and ho-
mogenous induction of HoxB4 and to enable reversibleWe used the same retroviral construct to infect cells
from day 6 EBs and found that HoxB4 expression pro- HoxB4 expression in vitro and in engrafted animals, we
generated a tetracycline-inducible HoxB4 transgene induced a similar outgrowth of hematopoietic blast cells
on OP9 stroma (not shown). However, our results with ES cells. First, we inserted the reverse tetracycline trans-
activator (rtTA; Gossen et al., 1995) by homologous re-yolk sac cells suggested that constitutive retroviral ex-
pression might have undesirable effects on hematopoi- combination into the constitutively active ROSA26 locus
Cell
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Figure 3. Effect of Doxycycline Induction of
HoxB4 on EB Cells In Vitro
(A) Colony formation by cells from day 6 EB
controls, and day 6 EBs treated with doxycy-
cline from day 4 to day 6, in hematopoietic
methylcellulose suspension culture. HPP-
GEMM refers to dense GEMMs not normally
seen at day 6 of EB development.
(B) Morphology of a typical day 6 GEMM.
(C) Morphology of a doxycycline-induced
HPP-GEMM at the same magnification as
in (B).
(D) A colony of semiadherent cells from
HoxB4-induced day 6 EB cells plated on OP9
in the presence of doxycycline.
(E) Cytospin preparation of these cells grow-
ing on OP9.
(F) Colony-forming activity of doxycycline-
induced cells grown on OP9 in methylcellu-
lose with myeloid cytokines. Control indicates
doxycycline not added to methylcellulose cul-
tures; dox indicates doxycycline induction
maintained during methylcellulose culture.
(G) Cytospin preparation from a GEMM ob-
tained from cultures described in (F). Open
arrowheads show erythroblasts; filled arrow-
head shows megakaryocyte.
(Zambrowicz et al., 1997). Then, we introduced a tar- immature multipotential myeloid progenitor detectable
in this assay, the CFU-GEMM (Figure 3A). CFU-GEMMgeting site upstream of the HPRT locus such that site-
specific integration of transgene constructs would re- from uninduced EBs were sparse with a relatively limited
erythroid burst, whereas HoxB4 induction generatedgenerate a functional antibiotic resistance gene (NEO),
thereby facilitating efficient selection of transgenic cells larger, denser colonies that resembled CFU-GEMM from
bone marrow (Figures 3B and 3C). We cultured cells(Figure 2; Wutz et al., 2002).
FACS analysis of a transgenic ES cell line targeted from the day 6 EBs on OP9 stroma in media supple-
mented with cytokines and doxycycline to maintainwith a GFP reporter construct demonstrated no detect-
able reporter expression in uninduced ES cells, thereby HoxB4 expression. This yielded colonies of semiadher-
ent cells with hematopoietic blast-like morphology (Fig-confirming the low basal rate of the conditional promoter
(Figure 2B, i). Following induction with the tetracycline ures 3D and 3E) that closely resembled the HoxB4-trans-
duced yolk sac cells grown under comparable liquidanalog doxycycline, GFP was readily detected in undif-
ferentiated cultures of ES cells (Figure 2B, ii). Robust culture conditions (Figure 1A). The expanded cells gen-
erated definitive myeloid colony types in methylcelluloseexpression was also seen when induction was started
at day 8 of EB differentiation and maintained for 48 hr media (Figures 3F and 3G). We characterized the cul-
tured cells for surface antigen expression by FACS and(Figure 2B, iii). Thus, the GFP reporter was free from the
transgene silencing frequently seen in differentiated ES found that the majority expressed the HSC markers c-kit
and CD31 (Table 1). In addition, we noted minor popula-cells. We then targeted HoxB4 into the inducible locus
and tested for expression of HoxB4 protein by Western tions of cells that expressed differentiation markers of
the myeloid (Mac-1 and Gr-1) and, to a lesser extent,blotting with a monoclonal antibody to HoxB4 (Gould et
al., 1997). Expression was detectable only in doxycy- erythroid (Ter119) and lymphoid (B220) lineages. Thus,
the cultured cells consist of immature hematopoieticcline-induced cells (Figure 2C).
We tested the effect of HoxB4 induction on hemato- progenitors undergoing substantial self-renewal and
modest differentiation in culture.poiesis by exposing EBs to doxycycline from day 4 to
day 6 of differentiation, the time at which the hemangi-
oblast undergoes commitment to the primitive HSC Markers of Definitive Hematopoiesis
in HoxB4-Modified Progenitors(Perlingeiro et al., 2001). At day 6 the EBs were dissoci-
ated and plated in methylcellulose suspension culture To determine whether HoxB4 expression in cultured
primitive yolk sac and ES-derived progenitors might in-to score for hematopoietic colony-forming cells. HoxB4
induction had a marked stimulatory effect on the most duce expression of genes linked to the primitive-defini-
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Table 1. FACS Analysis of HoxB4-induced EB-Derived Cells Grown
on OP9
Surface Antigen Expression of HoxB4-Induced ES-Derivatives
Lineage Antigen Percent Positive Cells
Myeloid Gr-1 5.6
Mac-1 21.0
Erythroid Ter119 0.7
Lymphoid B220 0.6
CD4 0.0
CD8 0.0
Progenitor/Megakaryocytic CD41 47.8
Pan-hematopoietic CD45 17.0
HSC c-kit 80.7
Sca-1 5.4
HSC/Endothelial CD31 78.0
AA4 0.7
CD34 0.5
Flk-1 0.0
tive transition, we analyzed these populations by RT-
PCR. The yolk sac from day 8.25 embryos expressed
both embryonic -H1 and adult-type -major globins
Figure 4. RT-PCR Analysis(Figure 4). In contrast, HoxB4-modified yolk sac and ES-
Samples included day 8.25 yolk sac (YS), HoxB4-transduced yolkderived populations all showed silencing of -H1 globin
sac cells (YS:rv-HoxB4), HoxB4-transduced day 6 EB cells grownin favor of expression of -major, suggesting that
on OP9 (EB:rv-HoxB4), OP9 alone, HoxB4-induced day 6 EB cells
HoxB4-expression and growth on OP9 stroma extin- grown on OP9 (EB-iHoxB4), and a no DNA control (neg). Samples
guished primitive erythroid potential (Figure 4). The small were normalized by dilution to give equivalent signals for actin.
amount of -H1 seen in the retrovirally transduced EB
sample (EB:rv-HoxB4) is likely due to contamination with
uninfected cells. We also examined two genes important tion, all animals showed mixed chimerism with donor
for homing of the definitive hematopoietic stem cell to and host-derived cells. Maintenance of HoxB4 induction
the adult bone marrow: CXCR4, required for stem cell in vivo was not necessary for sustained donor en-
homing after transplantation (Peled et al., 1999), and graftment, suggesting that HoxB4 expression during in
TEL, which plays a critical role in the transition of hema- vitro culture was sufficient to confer definitive potential
topoiesis from the fetal liver to the bone marrow (Wang (Figure 5B, left). We detected donor-derived GFP cells
et al., 1998). Neither CXCR4 nor TEL were detectable in expressing the HSC markers c-kit, Sca-1, and AA4 in
yolk sac, but both were expressed in HoxB4-modified the bone marrow of engrafted mice, suggesting that the
yolk sac and ES-derived hematopoietic populations transplanted cells were represented in the hematopoi-
(Figure 4). We conclude that HoxB4 expression, com- etic stem cell pool (Figure 5A).
bined with expansion on OP9 stroma, confers markers To assess whether long-term repopulating HSCs were
of definitive hematopoiesis on these cells of primitive generated, we transplanted donor-derived bone marrow
embryonic origin. cells from engrafted primary mice into secondary re-
cipients and detected donor cells in secondary mice
over 5 months (Figure 5B, right). The donor and second-Engraftment of ES-Derived Hematopoietic
ary recipients were not exposed to doxycycline, allow-Progenitors in Irradiated Mice
ing us to assess the intrinsic potential of the cells in theWe transplanted HoxB4-induced ES-derived hemato-
absence of HoxB4 transgene expression. FACS analy-poietic cells into irradiated syngeneic mice in order to
sis of peripheral blood demonstrated multilineage do-assay their ability to engraft and differentiate in the adult
nor contributions to both myeloid (GR-1) and lym-environment. For this purpose, cells were first labeled
phoid (B220, CD4, and CD8) compartments (Figureby infection with the MSCViresGFP retrovirus and FACS
5C). These data demonstrate long-term, multilineage,sorted for GFP cells before intravenous injection. Using
lymphoid-myeloid hematopoiesis in both primary andGFP expression as a marker, we found that 5%–32% of
secondary animals engrafted with hematopoietic pro-bone marrow mononuclear cells were donor derived 2
genitors derived from ES cells by reversible HoxB4 ex-weeks posttransplant, demonstrating that injected cells
pression.could home to the bone marrow. At 15 weeks posttrans-
plant, substantial contributions to myeloid and lymphoid
lineages were detected by simultaneous two-color de- Discussion
tection of GFP and differentiation markers for myeloid
(Gr-1, Mac-1), B lymphoid (B220), and T lymphoid (CD4, We have shown that expression of HoxB4 in primitive
hematopoietic progenitors from yolk sac or differenti-CD8) lineages (Figure 5A, right upper quadrants, all
graphs). We monitored GFP donor cells over time in ated ES cells, combined with culture on OP9 stroma,
promotes the expansion of hematopoietic populationsengrafted mice by serial sampling of peripheral blood
(Figure 5B). Despite exposure to 1000 cGy of  irradia- with definitive hematopoietic stem cell potential. The
Cell
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Figure 5. Engraftment of ES-Derived Hematopoietic Progenitors in Irradiated Primary and Secondary Mice
(A) FACS analysis of bone marrow of a representative recipient mouse (111N) 15 weeks posttransplant. Fluorescence intensity of GFP (marking
donor cells) indicated on x axis; fluorescence intensity of differentiation markers, as indicated, on y axis. Percentages represent the fraction
of GFP donor cells that express a given surface antigen.
(B) Percent GFP donor-derived cells in the peripheral blood of primary and secondary recipients as detected at indicated time points
posttransplant. Triangles indicate mice provided with doxycycline in their drinking water. Squares indicate mice not treated with doxycycline.
(Left) Five primary mice followed over 3 months. (Right) Four secondary mice injected with GFP bone marrow from a primary mouse (111L,
never exposed to doxycycline) followed over 5 months, without doxycycline.
(C) FACS analysis of peripheral blood from one secondary recipient stained for the myeloid differentiation marker Gr-1, the B cell marker
B220, and two T cell markers, CD4 and CD8. GFP intensity indicated on x axis; intensity of differentiation markers indicated on y axis. The
host cells, which serve as internal controls for antibody staining, are represented in the left upper and lower quadrants of all graphs. Percentages
represent the fraction of GFP donor cells that express a given differentiation antigen (right upper quadrants, all graphs).
cultured cells express several HSC markers, including the adult isoform of -globin as well as CXCR4 and
TEL, suggesting that they have undergone a switch fromc-kit, Sca-1, and CD31, and are rich in hematopoie-
tic colony forming cells, particularly multipotent CFU- primitive to definitive hematopoietic phenotype. Most
importantly, they engraft and repopulate long-term lym-GEMMs. In contrast to the embryonic tissues from which
they originated, the cultured cells exclusively express phoid-myeloid hematopoiesis in irradiated primary and
HoxB4 Enables Engraftment of Embryonic HSC
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secondary recipients, thereby satisfying the functional unpublished results), suggesting that this functional po-
definition of the definitive hematopoietic stem cell. tential is specific to HoxB4.
Previous attempts at stable long-term hematopoietic Although in vitro-generated, ES-derived HSCs engraft
engraftment of adult mice using differentiated ES cells productively in mice, they reconstitute with a mixture of
have proven ineffective. One study demonstrated only endogenous and donor-derived hematopoiesis. Thus,
limited lymphoid engraftment for embryoid body-derived additional work remains to understand the competitive
cell populations differentiated for 11–22 days in culture profile of ES-derived HSCs compared to their counter-
(Mu¨ller and Dzierzak, 1993). Another study claimed to parts in fetal liver and adult bone marrow. We have
demonstrate long-term hematopoietic engraftment from obtained superior lymphoid engraftment from ES cells
embryoid body populations differentiated for only 4 days using inducible HoxB4 expression from the tetracycline
(Hole et al., 1996). However, this latter report provided response element. In yolk sac cells, retroviral expression
scant characterization of engrafted donor cell popula- of HoxB4 seems to favor myeloid differentiation. A simi-
tions, relying upon forward and side scatter features of lar effect has been observed in cord blood cells overex-
circulating cells rather than defined markers of hemato- pressing HoxB4 (Brun et al., 2001) and with other Hox
poietic differentiation. Injection of EB-derived cells from genes (Buske et al., 2001; Sauvageau et al., 1997). Al-
this early time point, when significant numbers of undif- though transient conditional expression of HoxB4 is su-
ferentiated ES cells persist, can result in engraftment perior to constitutive retroviral expression for generating
of circulating nonhematopoietic cells with high tumor- long-term hematopoietic repopulation, the latter is suffi-
forming potential (Mu¨ller and Dzierzak, 1993; our unpub- cient to enable complete donor hematopoietic chime-
lished observations). Transient lymphoid contribution rism and partial reconstitution of immune function in the
has been observed with B220 cells from 20-day-old immunodeficient mouse model of combined gene and
EBs and longer-term lymphoid contribution from AA4/ cell therapy described in the accompanying paper (Ride-
B220 cells from the same EBs (Potocnik et al., 1997), out et al., 2002 [this issue of Cell]).
but never robust lymphoid-myeloid engraftment that The classical view of mammalian hematopoietic de-
can be carried into secondary hosts. The fact that the velopment held that hematopoietic stem cells originate
stem cell for embryonic erythropoiesis is able to produce in the yolk sac, migrate to the fetal liver, and ultimately
definitive lineages was established by transforming settle in the bone marrow. More recent work has shown
these cells with the oncogene Bcr/Abl, which enabled that lymphoid potential and long-term adult-repopulat-
single cells from day 5 EBs to produce primitive ery- ing cells arise at a distinct intraembryonic locale (Cu-
throid colonies in vitro and definitive lymphoid and my- mano et al., 1996, 2001; Medvinsky and Dzierzak, 1996;
eloid progeny in adult hosts (Perlingeiro et al., 2001). Muller et al., 1994; Sanchez et al., 1996), leading to a
The present work represents a less disruptive way to revised view that primitive and definitive hematopoietic
target this cell population, by expressing genes that are progenitors have distinct origins. Our work and others
normally active in the definitive HSC. HoxB4 is ideal in (Matsuoka et al., 2001; Toles et al., 1989; Weissman
this regard because its expression confers a competitive et al., 1978; Yoder et al., 1997), showing that primitive
advantage on transplanted bone marrow cells without embryonic progenitors can contribute to definitive
giving rise to leukemia (Sauvageau et al., 1995). hematopoiesis, suggests that there may yet be some
The possible role of HoxB4 in promoting definitive validity to the classical view. ES cell differentiation reca-
hematopoiesis was suggested by a comparison of Hox pitulates aspects of both primitive and definitive hema-
gene expression studies, which identify HoxB3, A4, B4, topoiesis in vitro. With the demonstration of hematopoi-
and A5 expression in definitive HSC (Sauvageau et al., esis from human ES cells (Kaufman et al., 2001) and a
1994) but not yolk sac (McGrath and Palis, 1997). As growing interest in therapeutic applications of differenti-
defined by extinction of embryonic globin gene expres- ated cells for regenerative medicine, understanding the
sion and acquisition of adult engraftment and lymphoid-
key features that distinguish primitive and definitive he-
myeloid differentiation potential, our results suggest that
matopoiesis may have future clinical significance.
HoxB4 can induce primitive embryonic progenitors to
acquire properties characteristic of the adult hemato- Experimental Procedures
poietic stem cell. The fact that expression of a single
selector gene can promote this switch in precirculation Cell Culture
yolk sac cells suggests that such cells are poised to ES cells were maintained on irradiated MEFs in DME/15% IFS, 0.1
mM nonessential amino acids (GIBCO), 2 mM glutamine, penicillin/become definitive HSC, but whether HoxB4 regulates
streptomycin (GIBCO), 0.1 mM -mercaptoethanol, and 1000 U/mLthis fate decision in the embryo is unknown. There is
LIF (Peprotech). For EB differentiation, ES cells were trypsinized,considerable redundancy of function among Hox gene
collected in EBD (IMDM/15% IFS, 200 g/mL iron-saturated trans-
paralogs, and other Hox genes, like HoxA4, may be ferrin [Sigma], 4.5 mM monothiolglycerol [Sigma], 50 g/mL
equally capable of promoting this switch. Besides Hox ascorbic acid [Sigma], and 2 mM glutamine), and plated for 45 min
genes, other transcription factors such as CBFA2 may to allow MEFs to adhere. Nonadherent cells were collected and
also play a role in specifying definitive hematopoiesis plated in hanging drops at 100 cells per 10 l drop in an inverted
bacterial petri dish. EBs were collected from the hanging drops at(North et al., 1999). Alternatively, HoxB4 may be acting
day 2 and transferred into 10 ml EBD in slowly rotating 10 cm petriin a nonphysiological way, by promoting proliferation or
dishes. At day 4, EBs were fed by exchanging half of their spentenabling the engraftment of a cell that is not normally
medium for fresh EBD. Cells were harvested at day 6 by collagenase
fated to give rise to definitive hematopoiesis. However, treatment. Retroviral supernatants were produced in 293 cells by
attempts to drive long-term engraftment using other FUGENE cotransfection, according to the manufacturer’s specifica-
growth-promoting genes, like activated forms of STAT5 tions, of viral plasmid with packaging-defective helper plasmid, pCL-
Eco (Naviaux et al., 1996). 293 cells were grown in DME/10% inacti-and the cytokine receptor c-mpl, were unsuccessful (our
Cell
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vated fetal calf serum (IFS), and medium was replaced the day after RT-PCR
Primers: actin(f) 5-GTGGGGCGCCCCAGGCACCA-3; actin(r)transfection. A total of 105 EB or 104 yolk sac cells were resuspended
in 3 ml of retroviral supernatant with 4 g/mL polybrene and cyto- 5-CTCCTTAATGTCACGCACGATTTC-3; -H1(f) 5-AGTCCCCA
TGGAGTCAAAGA-3; -H1(r) 5-CTCAAGGAGACCTTTGCTCA-3;kines (100 ng/mL SCF, 40 ng/mL VEGF, 40 ng/mL TPO, 100 ng/mL
Flt-3 ligand), transferred to semiconfluent OP9 cells in 6-well dishes, -maj(f) 5-CTGACAGATGCTCTCTTGGG-3; -maj(r) 5-CACAAC
CCCAGAAACAGACA-3; CXCR4(f) 5-TCAAGCAAGGATGTGACTTand centrifuged at 2500 rpm for 90 min at 33C. After spin-infection,
cells were returned to 37C for overnight incubation, and the next CGA-3; CXCR4(r) 5-AGGTCCTGCCTAGACGCTCATT-3; TEL(f)
5-CTGAAGCAGAGGAAATCTCGAATG-3; and TEL(r) 5-GGCAGGmorning the medium was exchanged for IMDM/10% IFS and the
same cytokines. When confluent, the cultures were passaged by CAGTGATTATTCTCGA-3. Cycle conditions: 2 min at 94C; 30 cy-
cles of (45 s at 95C; 1 min at 60C; 1 min at 72C); 5 min at 72C.pooling suspension and semiadherent cells (obtained by trypsiniza-
tion) and replated onto fresh OP9. Colony assays were done in
methylcellulose medium with IL3, IL6, Epo, and SCF (M3434, Stem- Acknowledgments
Cell Tech.).
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